SRPT FY 2023 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.2B+33.3% YoY

Gross Profit

$1.1B87.9% margin

Operating Income

-$268M-21.5% margin

Net Income

-$536M-43.1% margin

EPS (Diluted)

$-5.80

Cash Flow

Operating Cash Flow

-$501M

Free Cash Flow

-$588M

Stock-Based Comp.

$183M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$2.4B

Stockholders' Equity

$859M

Cash & Equivalents

$428M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$933M	+33.3%
Gross Profit	$1.1B	$793M	+37.8%
Operating Income	-$268M	-$536M	+50.1%
Net Income	-$536M	-$703M	+23.8%